# 6 findings from new GLP data 👀 #glp1 #hormones #longevity #scienceupdate #researchupdate

## Метаданные

- **Канал:** Jonathan Schoeff
- **YouTube:** https://www.youtube.com/watch?v=gZ0EvWGblKk
- **Дата:** 14.05.2026
- **Длительность:** 1:13
- **Просмотры:** 4,756
- **Источник:** https://ekstraktznaniy.ru/video/51259

## Транскрипт

### Segment 1 (00:00 - 01:00) []

Here's the top six finding from the recently released GLP-3 or Retatrutide research that will make you rethink everything when it comes to metabolic optimization. I'm Dr. Jonathan Schedlongevity medicine expert and I work with GLP's every single day. Here's what jumps off the page from the recently released phase three data around Retatrutide. Number one, 28. 7% average body weight loss over 68 weeks. This is the highest number ever recorded in a pharmaceutical trial on obesity ever. Number two, 72% of people with pre-diabetes reverted to normal blood sugar levels. Number three, 86% reduction in liver fat. In patients with fatty liver disease, nine out of 10 of those patients had their liver fat normalized completely. Number four, 41% of participants were able to stop their blood pressure medication entirely during the trial. This speaks to something I bring up all the time. High blood pressure is often times linked to insulin resistance. Fix the root cause. Number five, systolic blood pressure. It dropped by 14 mm of mercury. That's a number that most blood pressure medications aim for and struggle to hit. And number six, triglycerides dropped by up to 36%. Triglycerides are one of the strongest predictors of cardiovascular disease. A 36% reduction is clinically significant. All of this from one compound, one drug, one weekly injection and we're still wrapping up the phase three clinical trials. The full picture is yet to come.